4.3 Review

Cervicosacropexy or vaginosacropexy for urinary incontinence and apical prolapse: A systematic review

Publisher

ELSEVIER
DOI: 10.1016/j.ejogrb.2022.10.004

Keywords

Apical prolapse; Cervicosacropexy (CESA); Efficacy; IDEAL; Safety; Urinary incontinence; Vaginosacropexy (VASA)

Ask authors/readers for more resources

This systematic review aimed to summarize the evidence on the efficacy and safety of cervicosacropexy and vaginosacropexy as alternative surgical treatment options for urge and/or mixed urinary incontinence and apical prolapse. The included studies showed moderate-to-high risk of bias and low certainty of evidence. Cervicosacropexy or vaginosacropexy may remedy symptoms of urge and mixed urinary incontinence and seem to correct apical prolapse in the short term, but further clinical trials are needed to improve patient selection and use validated outcome measures.
Several anatomic theories suggest that lax uterosacral ligaments may result in apical prolapse and urinary in-continence. Therefore, prolapse repair such as cervicosacropexy or vaginosacropexy, may resolve urinary in-continence. Shortcomings in current treatment options endorse further exploration of the potential benefit of a surgical alternative.This systematically review of the literature aimed to summarize the evidence on the efficacy and safety of cervicosacropexy and vaginosacropexy as alternative surgical treatment options for urge and/or mixed urinary incontinence and apical prolapse. The PRISMA 2020 statement was followed and the review protocol was registered with PROSPERO (CRD42021267941). Studies from inception to 9/2021 were systematically reviewed and included. Data collection, risk of bias, and certainty of evidence were assessed using the standard Cochrane methods. The primary outcome measures were improvements in prolapse and urinary symptoms. Secondary outcomes included surgical safety and reintervention rates for complications and recurrence.The included studies showed a moderate-to-high risk of bias and low certainty of evidence. Owing to their heterogeneity, no meta-analysis was performed. Cure rates for mixed and urge urinary incontinence and apical prolapse were 47.5 % (CI95%:42.4-52.6), 73.8 % (CI95%:61.9-85.7) and 97-100 % respectively, at a mean follow-up of 9.7 +/- 7.3 months. Additional incontinence surgery in 38.9 % (216/555) of women with initial urinary incontinence, and concomitant or subsequent surgery for prolapse was performed in 4.4 % (13/299).Cervicosacropexy or vaginosacropexy may remedy symptoms of urge and mixed urinary incontinence and seem to correct apical prolapse in the short term. Nevertheless, the overall level of evidence is low. Therefore, further clinical trials, integrated in the IDEAL framework, targeting better-identified patient selection, and using validated outcome measures are needed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available